EUVIMEDEUVIMED entdecken
Crossref

From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials

Keith L. Carson

BioProcessing Journal · 27.07.2026 · 6

DOI: 10.12665/j72.kcarson ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are many examples of efforts to make biosimilar products, such as every time a product is taken to a larger scale, and when an established product is transferred to another facility, including a contract manufacturing site. While most of these examples have resulted in products which were indistinguishable for all practical purposes, others revealed troubling differences during product characterization or clinical administration...

Zitieren

APA

Carson, K. L. (2026). From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal, 6. https://doi.org/10.12665/j72.kcarson

Vancouver

Carson KL. From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal. 2026:6. doi:10.12665/j72.kcarson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {6},
  doi = {10.12665/j72.kcarson}
}
Kostenlos starten →